Johnson & Johnson International (Singapore) is collaborating with the Singapore Economic Development Board (EDB) to boost innovation in Singapore’s life sciences sector. The first-of-its-kind partnership involves leveraging Johnson & Johnson Innovation – JLABS’ services to support early-stage companies in Singapore, helping them transform their discoveries into innovative healthcare solutions. JLABS will also work with local incubators and partners to drive employment and commercialization opportunities for these early-stage firms. This collaboration underscores Johnson & Johnson’s commitment to fostering healthcare innovation in the Asia Pacific region.
The initiative builds on JLABS’ extensive experience and global network, which includes startups, investors, and corporate partners. The company will co-host a symposium in Singapore with EDB, with further developments expected from this partnership. Johnson & Johnson Innovation – JLABS is known for its open innovation ecosystems, supporting emerging companies across various healthcare sectors to deliver life-enhancing solutions to patients. It operates with a no-strings-attached model, allowing innovators to retain their intellectual property while developing their technology.
(Source: Johnson & Johnson)
